***  For details on how to be removed from this list visit the  ***
***          CCP4 home page http://www.ccp4.ac.uk         ***


Hi,

I already replied to the author directly, but here's a comment that may be useful to the board in general: beware of inhibitors that look 'decent' but are in fact non-specific. We've encountered a whole lot of those (hundreds per project - many thousands if I count across projects), and it is sometimes maddeningly difficult to distinguish between real inhibitors and the aggregate-forming hydrophobic junk. An enzyme assay performed in the presence of 0.1% BSA helps a lot, but can still be tricked by some of the more persistent 'junk inhibitors'.

These inhibitors often have the following characteristics:

1. relatively large (usually over 200 Da)
2. poorly soluble, and often forming colloids and aggregates (detectable by DLS, for instance) 3. have mostly hydrophobic character but also one or two hydrophilic groups (I call them nano-soap) 4. they often inhibit multiple unrelated enzymes (like e.g. a beta-lactamase and a kinase and a phosphatase and a protease) at similar concentrations 5. assay results look OK for IC-50 but if you do true kinetics, they start looking very iffy (but alas, not for all of the inhibitors!)

Please note that we've had a fair share of 'true' inhibitors that also exhibited nonspecific enzyme killing at higher (or even the same) concentrations as their 'real' activity.

So, if your favorite compound happens to be e.g. a rhodamine derivative, or a conjugated phenol, or a scary branched-aromatic lobstrosity with one lonely hydroxy or carboxy group on the end - there's a very good chance that the inhibition is nonspecific.

Artem


----- Original Message ----- From: "Tiancen Hu" <[EMAIL PROTECTED]>
To: "Juergen Bosch" <[EMAIL PROTECTED]>
Cc: "ccp4bb" <[email protected]>
Sent: Monday, December 19, 2005 3:35 AM
Subject: Re: Re: [ccp4bb]: Failed in co-crystallizing inhitors


***  For details on how to be removed from this list visit the  ***
***          CCP4 home page http://www.ccp4.ac.uk         ***


Hi, Juergen

Thanks for your help!

Our most interested inhibitor has a fairly good solubility, it didn't precipitate in both 2% and 10% DMSO. However, other inhibitors precipitated more or less after being added to the protein solution. Do you think adding the stock solution of the inhibitors (in 100% DMSO) stepwisely and slowly into the protein solution could help them dissolve better? Solubility is really a big problem to us working on protein:inhibitor complexes.

Now I think not including the inhibitors in the cryo-portectant is very likely to be the cause of inhibitors missing in my map, like you and many other CCP4bb users, Jeffery Ohren, George Wisedchasri, Ekstrom Fredrik, Anthony Addlagatta have all mentioned to me. Thanks for all the quick responses, they're very helpful to me. I will add ligands in the cryo next time.

Yes, the F(complex)-F(uncomplexed) difference map is what I need. I found this method in an old post by Zsolt Bocskei in 2001, he mentioned that Gerard Bricogne had suggested him using F(complex)-F(uncomplexed) instead of F(complex)-F(calculated from the model) to construct difference map for inspecting ligands. I am a newbie in protein crystallography, and I am not clear about the difference between them. Could any one give me some idea?

Thanks again!

Tiancen Hu






======= 2005-12-19 01:47:16 您在来信中写道:=======

Hi Tony,

Protein : inhibitor mixture:

[protein]: 10mg/ml, ~0.3mM

[inhibitor]: ~2mM (with 2%DMSO in the mixture) or ~10mM (with 10%DMSO)

The protein and inhibitors were incubated on ice for >3hr.

The MWs of the inhibitors are all larger than 400.

You assume that you have a monomer in the asu ? If you have more than
that you might want to take the ratio into account for your excess
amount of inhibitor. Is your inhibitor sufficiently soluble in 2% DMSO ?

Reservoir: 0.1M Hepes pH 7.5, 0.1-0.4M Mg(Ac)_2 , 10-20% PEG4K / PEG6K
/ PEG8K (different inhibitor:protein mixture produces crystals in
different combination of Mg(AC)_2 concentration and PEG)

Cryo-protectant: 30% Glycerol added to the same mother liquor,
crystals soaked for 1min �C 5min before being flash cooled in liquid
nitrogen.

Did your Cryo contained the inhibitors in the same or even higher
concentration as your original setup for co-crystallization ? If not you
have reduced the [Inhibitor] bei almost 1/3.

6 sets of data were collected, 1 from native crystal, 2 from “2mM
inhibitor” crystals, 3 from “10mM inhibitor” crystals (one of the
inhibitor “produced” crystals both at 2mM and 10mM).

The qualities of the datasets are all good, but the result was
frustrating, I couldn’t find any “inhibitor-like” density map from any
of these datasets. So these are my questions:

1. What could be the possible reasons for these inhibitors missing in
the density map? I suspected that it could be the high DMSO
concentration in the mixture, or the high glycerol concentration in
the cryo-protectant, or that I soaked the crystals in the
cyro-protectant for too long, which caused the inhibitors “drop off”
from the protein. If so, how could I deal with them?

Increase the [Inhibitor] in the cryo.

2. I constructed the difference map from the measured amplitudes of
“complex” crystals and the structure factors of a model downloaded
from PDB. And I happened to read from the ccp4bb archive that there is
also a way of calculating difference map between the measured
amplitudes from the “complex” and those from native crystals. But I
have no idea how to do this, could any one give me some advice?

I think you want to use F(complex)-F(uncomplexed) ? or 2Fc - Fu. If that
is the case you need to scale the two differnet datasets first and then
run fft with the correct labels.

Not sure if I understood you correctly here.

Juergen

Thanks in advance!

Tiancen Hu

Drug Discovery and Design Center

Shanghai Institute of Materia Medica

Room 2107, #555, ZuChongzhi Road

Shangahi 201203, P.R. China

Phone: 0086-(0)21-50806600 ext. 2107

Email: [EMAIL PROTECTED]












完 全 免 费 & 无 限 容 量 = 你 的 网 易 相 册
<http://adclient.163.com/event.ng/Type=click&FlightID=46628&AdID=48547&TargetID=635&Segments=80,94,289,416&Targets=1758,92,635&Values=31,43,51,60,72,78,82,91,100,110,150,312,330,332,457,499,586,615,702,733,734&RawValues=&Redirect=http://photo.163.com/>



--
Jürgen Bosch
Howard Hughes Medical Institute and
University of Washington
Dept. of Biochemistry, K-418
1705 NE Pacific Street
Seattle, WA 98195
Box 357742
Phone: +1-206-616-4542
FAX: +1-206-685-7002

= = = = = = = = = = = = = = = = = = = =


        致
礼!


        Tiancen Hu
[EMAIL PROTECTED]
          2005-12-19


Reply via email to